Evidence map›Paper›PMID 27510032›Full record

ArticleThe Journal of biological chemistry2016

The Histamine H3 Receptor Differentially Modulates Mitogen-activated Protein Kinase (MAPK) and Akt Signaling in Striatonigral and Striatopallidal Neurons.

Maximiliano Rapanelli, Luciana R Frick, Kyla D Horn, Rivka C Schwarcz, Vladimir Pogorelov, Angus C Nairn, Christopher Pittenger

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Reciprocal regulation of the HbioRxiv : the preprint server for biology · 2025
    Article
  3. Sex Differences in Histamine Regulation of Striatal Dopamine.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  4. The Interaction of Histamine HPharmaceuticals (Basel, Switzerland) · 2024
    Review
  5. Chronic HPsychopharmacology · 2023
    Article
  6. Article
  7. Review
  8. Different Peas in the Same Pod: The Histaminergic Neuronal Heterogeneity.Current topics in behavioral neurosciences · 2022
    Review
  9. Article
  10. White matter abnormalities in theFrontiers in molecular neuroscience · 2022
    Article
  11. Histamine HBiological psychiatry · 2021
    Article
  12. The Multi-Targeting Ligand ST-2223 with Histamine HInternational journal of molecular sciences · 2021
    Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Histaminergic Control of Corticostriatal Synaptic Plasticity during Early Postnatal Development.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Maximiliano RapanelliFrom the Departments Psychiatry and.ORCID http://orcid.org/0000-0001-7329-2364
Luciana R FrickFrom the Departments Psychiatry and.ORCID http://orcid.org/0000-0001-5595-8636
Kyla D HornInterdepartmental Neuroscience Program, and.ORCID http://orcid.org/0000-0001-8340-3654
Rivka C SchwarczGraduate Program in Cell Biology, Yale University, New Haven, Connecticut 06519.
Vladimir PogorelovFrom the Departments Psychiatry and.
Angus C NairnFrom the Departments Psychiatry and angus.nairn@yale.edu.ORCID http://orcid.org/0000-0002-7075-0195
Christopher PittengerFrom the Departments Psychiatry and Interdepartmental Neuroscience Program, and Psychology, Child Study Center, christopher.pittenger@yale.edu.ORCID http://orcid.org/0000-0003-2117-9321
Institute of Psychology · RUYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
THE ROLE OF DARPPS IN THE ACUTE AND CHRONIC EFFECTS OF COCAINE AND AMPHETAMINEP01DA010044 · NIDA · ROCKEFELLER UNIVERSITY · PI GREENGARD, PAUL · 1996 to 2015
$23.6M
Striatal Cell-specific Analysis of the Molecular Mechanisms of Antipsychotic DrugP50MH090963 · NIMH · ROCKEFELLER UNIVERSITY · PI NESTLER, ERIC J. · 2010 to 2014
$9.8M
Pathophysiologically Realistic Mouse Models of Neuropsychiatric Disease: TouretteR01MH091861 · NIMH · YALE UNIVERSITY · PI PITTENGER, CHRISTOPHER JOHN · 2010 to 2014
$2.0M
NCATS NIH HHS UL1 TR001863NIDA NIH HHS P01 DA010044NIMH NIH HHS P50 MH090963NIMH NIH HHS R01 MH091861
6 · The paper itself

Abstract

The basal ganglia have a central role in motor patterning, habits, motivated behaviors, and cognition as well as in numerous neuropsychiatric disorders. Receptors for histamine, especially the H3 receptor (H3R), are highly expressed in the striatum, the primary input nucleus of the basal ganglia, but their effects on this circuitry have been little explored. H3R interacts with dopamine (DA) receptors ex vivo; the nature and functional importance of these interactions in vivo remain obscure. We found H3R activation with the agonist R-(-)-α-methylhistamine to produce a unique time- and cell type-dependent profile of molecular signaling events in the striatum. H3 agonist treatment did not detectably alter extracellular DA levels or signaling through the cAMP/DARPP-32 signaling pathway in either D1- or D2-expressing striatal medium spiny neurons (MSNs). In D1-MSNs, H3 agonist treatment transiently activated MAPK signaling and phosphorylation of rpS6 and led to phosphorylation of GSK3β-Ser

Indexed as

AnimalsBenzazepinesCorpus StriatumDopamine and cAMP-Regulated Phosphoprotein 32Extracellular Signal-Regulated MAP KinasesGlycogen Synthase Kinase 3 betaLocomotionMAP Kinase Signaling SystemMiceMice, TransgenicPhosphorylationProto-Oncogene Proteins c-aktReceptors, Dopamine D1Receptors, Dopamine D2Receptors, Histamine H3Ribosomal Protein S6BenzazepinesDopamine and cAMP-Regulated Phosphoprotein 32Extracellular Signal-Regulated MAP KinasesGlycogen Synthase Kinase 3 betaGsk3b protein, mousePpp1r1b protein, mouseProto-Oncogene Proteins c-aktReceptors, Dopamine D1Receptors, Dopamine D2Receptors, Histamine H3Ribosomal Protein S6ribosomal protein S6, mouseSK&F 82958Akt PKBdopaminedopamine receptorH3RhistamineMAPKmedium spiny neuronstriatum

Identifiers

PMID27510032
PMCPMC5076514
OpenAlexW2527055114

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.